Portable drug mixing and delivery device and associated methods
A portable dual chamber auto-injector configured to store a dry opioid antagonist medicament separately from a liquid component, wherein a user actuated mixing system comprising a movable component to create a fluidic pathway between the first and second chambers and release a portion of energy from a pre-stored energy to drive a displacement mechanism into the first chamber and displace the liquid component into the second chamber and solubilize the opioid antagonist. A needle assembly in fluid communication with the second chamber can be used to transfer the solubilized opioid antagonist.
1. A dual chamber drug mixing system comprising:
a housing;
a first chamber and a second chamber disposed at least partially within the housing, the first chamber axially aligned with the second chamber, wherein the first chamber has an outlet, the outlet of the first chamber offset from a central longitudinal axis of the housing, and the second chamber has an inlet and wherein the first chamber and the second chamber are not in communication during a closed state;
a first medicament component provided in the first chamber;
a second medicament component provided outside the first chamber, the second medicament component including an opioid antagonist compound in the amount of 1 mg/kg to 25 mg/kg based on a recipient's weight;
a user operable mixing system having a first displacement mechanism, wherein when the user operable mixing system is activated, fluidic communication occurs between the outlet of the first chamber and the inlet of the second chamber and the first displacement mechanism within the first chamber drives the first medicament component into the second chamber; and
a valve disposed between the outlet of the first chamber and the inlet of the second chamber, wherein the valve is configured to open or close a fluidic pathway between the first chamber and the second chamber,
wherein the first chamber and the second chamber are configured to move within the housing independently with respect to each other, as the first chamber has a first sidewall and the second chamber has a second sidewall separate and distinct from the first sidewall.
2. The dual chamber drug mixing system of claim 1 , further comprising a needle assembly in fluid communication with an outlet of the second chamber.
3. The dual chamber drug mixing system of claim 1 , wherein the first displacement mechanism is mechanically coupled to the valve.
4. The dual chamber drug mixing system of claim 1 , wherein the first displacement mechanism causes the valve to align the outlet of the first chamber with the inlet of the second chamber.
5. The dual chamber drug mixing system of claim 1 , wherein the first displacement mechanism is rotatable.
6. The dual chamber drug mixing system of claim 1 , wherein the first displacement mechanism can be axially translated.
7. The dual chamber drug mixing system of claim 1 , wherein the second chamber is configured to axially move and expand a volume of the second chamber formed therein.
8. The dual chamber drug mixing system of claim 1 , wherein a volume of the second chamber is configured to expand as the second chamber moves axially during a mixing phase and contract as the second chamber moves axially during a delivery phase.
9. The dual chamber drug mixing system of claim 1 , wherein the second chamber is a cartridge having a seal disposed between the second chamber and a needle assembly.
10. The dual chamber drug mixing system of claim 1 , wherein the second chamber is a syringe component having a staked needle on one end, and wherein the staked needle forms an outlet to the second chamber.
11. The dual chamber drug mixing system of claim 1 , wherein the opioid antagonist is naltrexone.
12. A dual chamber medication mixing device comprising:
a housing containing a first chamber with an outlet offset from a central longitudinal axis and a second chamber having an inlet;
a first medicament component provided in the first chamber, wherein the first medicament component being provided in liquid form;
a second medicament component provided in the second chamber, the second medicament component being dry and including an opioid antagonist compound in the amount of 1 mg/kg to 25 mg/kg based on a recipient's weight;
a valve assembly being disposed between the first chamber and the second chamber, the valve assembly being configured to selectively allow fluid communication between the first chamber and the second chamber;
a user operable mixing system having a fluidic channel, the user operable mixing system configured to rotate about the central longitudinal axis to selectively align the fluidic channel with the valve assembly; and
a first displacement mechanism, the first displacement mechanism being configured to cause movement of the first medicament component from the first chamber into the second chamber, thus causing the first medicament component and the second medicament component to mix thus resulting in a mixed medicament compound;
wherein the opioid antagonist compound is naltrexone; and
a bump switch configured to activate a second actuation mechanism to drive the mixed medicament compound in the second chamber through a delivery assembly.
13. The dual chamber medication mixing device of claim 12 , wherein the delivery assembly includes a needle assembly in fluid communication with an outlet of the second chamber.
14. The dual chamber medication mixing device of claim 12 , wherein the first displacement mechanism is rotatable.
15. The dual chamber medication mixing device of claim 12 , wherein the first displacement mechanism can be axially translated.
16. The dual chamber medication mixing device of claim 12 , wherein the second chamber is configured to axially move and expand a volume of the second chamber formed therein.
17. The dual chamber medication mixing device of claim 12 , wherein a volume of the second chamber is configured to expand as the second chamber moves axially during a mixing phase and contract as the second chamber moves axially during a delivery phase.